The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung

$ 11.50

4.7
(344)
In stock
Description

科学家揭示非小细胞肺癌新的驱动因素与药物靶点- 专区- 生物谷

Identification of Ultrasound-Sensitive Prognostic Markers of LAML

Genotype-phenotype mapping of a patient-derived lung cancer

The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung

EGFR exon 20 insertion mutations and ERBB2 mutations in lung

Frontiers Recent progress in targeted therapy for non-small cell

Repotrectinib (TPX-0005) Datasheet

Recombinant Anti-LTK antibody [EPR5175(2)] (ab129155)

Rare molecular subtypes of lung cancer

The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung

PDF) ALK, ROS1, RET and NTRK1–3 Gene Fusions in Colorectal and Non